Robbins LLP Urges ADMA Stockholders Who Lost Money Investing in ADMA Biologics, Inc. Contact the Firm for Information About Leading the Class Action

SAN DIEGO, June 23, 2026 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ: ADMA) securities between August 9,2024 and March 25, 2026. ADMA Biologics, Inc., is a...